Newsfeeds Archive - Spark Newswire

4 minute read

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

June 14, 2:13 PM

Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday’s session following fourth-quarter results. AMMO reported a fourth-quarter profit…

ADBE

2 minute read

Dave & Buster’s Posts Downbeat Results, Joins J.Jill And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor

June 13, 5:51 AM

U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Thursday. Shares…

JACK

1 minute read

Ultragenyx Plans To File For Accelerated Approval Of UX111 For The Treatment Of Sanfilippo Syndrome Type A, After Meeting With FDA

By Benzinga Newsdesk

June 12, 4:00 PM

Agreement reached with FDA that cerebral spinal fluid (CSF) heparan sulfate (HS) can be used as a reasonable surrogate endpoint for accelerated approval Data from existing clinical studies appear sufficient for a

RARE

1 minute read

This United Airlines Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

By Avi Kapoor

June 6, 9:58 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

LULU

4 minute read

Analyst Ratings

Peeling Back The Layers: Exploring Ultragenyx Pharmaceutical Through Analyst Insights

By Benzinga Insights

May 31, 10:00 AM

In the last three months, 11 analysts have published ratings on Ultragenyx Pharmaceutical (NASDAQ:RARE), offering a diverse range…

RARE

1 minute read

Ultragenyx Announces Top-Line Results From Phase 3 Study of DTX401 Gene Therapy For Glycogen Storage Disease Type Ia

By Benzinga Newsdesk

May 30, 4:00 PM

Treatment with DTX401 resulted in a statistically significant reduction in daily cornstarch intake at Week 48 (p<0.0001) with maintenance of glucose control Company will host investor call today at 5:00 p.m.

RARE

2 minute read

Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks’ Cells

By Vandana Singh

May 22, 12:27 PM

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against Ultragenyx's motion to dismiss, allowing the case to continue.

RARE

2 minute read

Ultragenyx Announces Completion Of Enrollment In Phase 3 Orbit And Cosmic Studies Evaluating Setrusumab For The Treatment Of Osteogenesis Imperfecta

By Benzinga Newsdesk

April 30, 8:11 AM

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that all patients have been enrolled across the Phase 3 Orbit and Cosmic studies evaluating setrusumab (UX143) in pediatric and young adult patients with

RARE

4 minute read

Analyst Ratings

Forecasting The Future: 11 Analyst Projections For Ultragenyx Pharmaceutical

By Benzinga Insights

April 22, 8:00 AM

Ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) were provided by 11 analysts in the past three months, showcasing a mix…

RARE

3 minute read

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March

By Avi Kapoor

April 15, 2:30 PM

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&P 500 also fell, dropping, 1.14% to 5,065.04.

LGVN